Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes

Abstract

Gene delivery to the cerebral cortex is challenging due to the blood brain barrier and the labile and macromolecular nature of DNA. Here we report gene delivery to the cortex using a glycol chitosan—DNA polyplex (GCP). In vitro, GCPs carrying a reporter plasmid DNA showed approximately 60% of the transfection efficiency shown by Lipofectamine lipoplexes (LX) in the U87 glioma cell line. Aiming to maximise penetration through the brain extracellular space, GCPs were coated with hyaluronidase (HYD) to form hyaluronidase-coated polyplexes (GCPH). The GCPH formulation retained approximately 50% of the in vitro hyaluronic acid (HA) digestion potential but lost its transfection potential in two-dimensional U87 cell lines. However, intranasally administered GCPH (0.067 mg kg−1 DNA) showed high levels of gene expression (IVIS imaging of protein expression) in the brain regions. In a separate experiment, involving GCP, LX and naked DNA, the intranasal administration of the GCP formulation (0.2 mg kg−1 DNA) resulted in protein expression predominantly in the cerebral cortex, while a similar dose of intranasal naked DNA led to protein expression in the cerebellum. Intranasal LX formulations did not show any evidence of protein expression. GCPs may provide a means to target protein expression to the cerebral cortex via the intranasal route.

Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant Staphylococcus aureus

“…Our efforts focused on trying to replicate the original toxicity experiments (by CO-ADD) with tamoxifen using a protocol modified for use with 96-well plates. Given the variability of protocols and results in the literature, it was important to compare with a standard protocol we have reliably used in our own laboratories. − When both CC 50 values and D max were mapped against the other two experimental variables (i.e., recovery status after treatment (yes/no) and the detection output (MTT/resazurin)), the majority of compounds were found to be toxic, as classified by CO-ADD, with a small spread of the data for most variations of protocol used (Figure A). Truly “non-toxic” compounds might be expected to show D max < 50% for all experiment variations, e.g., 861 .…”

Interaction of γ-Polyglutamic Acid/Polyethyleneimine/Plasmid DNA Ternary Complexes with Serum Components Plays a Crucial Role in Transfection in Mice

“…Typical examples of non-viral vectors include complexes of plasmid DNA with cationic polymers or liposomes. In particular, various types of polymers are used for gene delivery, including polyethyleneimine [ 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ], poly-β-amino esters [ 15 , 16 , 17 , 18 ], chitosan [ 19 , 20 , 21 , 22 ], and dendrimers [ 23 , 24 ]. These complexes have been reported to exhibit high gene expression in vitro and in vivo.…”

Brain Targeting Nanomedicines: Pitfalls and Promise

“…To overcome these challenges, several administration routes have been explored including intranasal and intracranial routes. [20][21][22] Focusing on intravenous administration, nanosized carriers (nanoparticles (NPs), size >100 nm) 23 are increasingly being developed for more efficient drug delivery across the BBB for the treatment and diagnosis of a wide range of CNS diseases, such as cancer and neurodegenerative diseases. 5,[24][25][26] In addition, different precision targeting strategies (eg, functionalization with antibodies, ligand proteins or homing peptides) have been explored to facilitate drug uptake into the brain.…”